DigiTwo introduces learning solution for Prof 2 MBBS Students

IMT News Desk
IMT News Desk
· 2 min read

Comprehensive coverage includes microbiology, pathology and pharmacology with 370+ hours of video lectures

EdTech platform by Jaypee Brothers Medical Publishers, DigiNerve, has launched DigiTwo, an innovative learning combo designed specifically for Prof 2 MBBS students. Recently launched this comprehensive solution combines cutting-edge digital learning with expert-led instruction to strengthen students’ foundation in essential Prof 2 subjects.

DigiTwo’s expert faculty panel includes distinguished educators from microbiology, pathology and pharmacology. In microbiology, Dr Apurba S Sastry and Dr Anitha G bring expertise in infectious disease diagnostics, while Dr Madhu Choudhary contributes her experience in medical publishing. In pathology, Dr Harsh Mohan, Dr Debasis Gochhait and Dr Hirina Soni will provide insights into disease mechanisms and lab diagnosis. In pharmacology, Dr Nirmal George and Dr Sandeep Kaushal will guide students through drug actions and safety. Their collective expertise ensures a comprehensive, application-driven learning experience for medical students.

“DigiTwo represents a pivotal advancement in medical learning, addressing the evolving needs of today’s medical students,” said Ankit Vij, Managing Director, DigiNerve. “By combining comprehensive subject coverage with innovative learning tools, we’re not just preparing students for examinations but also fostering confident medical professionals who will shape the future of healthcare. The integration of Dr Wise AI Chatbot for AI-assisted learning with expert-led instruction sets a new benchmark in, making quality medical learning more accessible and effective than ever before.”

DigiTwo addresses the complexities of medical learning through an integrated approach, featuring over 320+ topics supported by detailed video lectures and printed notes. The package also includes a robust Question Bank with 2,000+ practice questions alongside 30+ OSCE modules for practical skill development. Students benefit from 450+ High-Yield GEMS for quick revision and regular webinars conducted by leading medical educators.

Setting new standards in medical learning technology, DigiTwo introduces the Dr Wise AI Chatbot for instant query resolution and personalized learning support. The platform’s structured test series enables students to track their progress while building confidence through regular assessment and detailed performance analysis.

Read Next

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya
News
June 5, 2026

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya

Union Health Minister J P Nadda on Thursday declared that the Central Government remains firmly committed to strengthening healthcare infrastructure across the Northeast and ensuring that advanced medical services reach people living in remote and underserved areas of the region. Nadda made these remarks while inaugurating ARHI Hospital in Meghalaya’s Ri-Bhoi district- a new super-specialty […]
Article by: IMT News Desk
Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today
News
June 5, 2026

Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today

Mumbai-based Hexagon Nutrition Ltd has mobilised Rs 41.66 crore from anchor investors ahead of its initial public offering (IPO), which opened for public subscription on June 5 and will remain open until June 9, 2026. According to a circular uploaded on BSE’s website, the company allotted a total of 92.57 lakh equity shares to anchor […]
Article by: IMT News Desk
Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval
News
June 5, 2026

Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval

Otsuka Pharmaceutical has reported that its approved kidney disease drug Voyxact (sibeprenlimab) preserved kidney function over 12 months in a late-stage clinical study, marking a significant milestone in the treatment of immunoglobulin A nephropathy (IgAN), a serious autoimmune condition that progressively damages the kidneys. In the Phase 3 VISIONARY trial involving 320 participants, patients who […]
Article by: IMT News Desk
Akums Receives European CEP Approval for Cefpodoxime Proxetil
News
June 4, 2026

Akums Receives European CEP Approval for Cefpodoxime Proxetil

Akums Drugs & Pharmaceuticals Ltd. has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its active pharmaceutical ingredient (API), Cefpodoxime Proxetil. The CEP certification confirms that Akums’ manufacturing process and quality standards for Cefpodoxime Proxetil comply with the requirements of the European Pharmacopoeia. The […]
Article by: IMT News Desk